Brief: Roquefort Therapeutics Extends Lyramid Sale Deadline To 31 October
Aug 28 (Reuters) - Roquefort Therapeutics PLC ROQ.L: ROQUEFORT THERAPTCS. - LYRAMID SPA 2ND EXTENSION & CARVE OUT ROQUEFORT THERAPEUTICS PLC - EXTENDS LYRAMID SALE DEADLINE TO 31 OCTOBER 2025 Source text: ID:nRSb9207Wa Further company coverage: ROQ.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts